![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/18/2915668/0/en/Appili-Therapeutics-Announces-Second-Amendment-to-Arrangement-Agreement.html
https://www.globenewswire.com/news-release/2024/07/02/2907327/0/en/Appili-Therapeutics-Announces-Amendment-to-Arrangement-Agreement-and-Increase-to-Bridge-Loan.html
https://www.globenewswire.com/news-release/2024/06/25/2904175/0/en/Appili-Therapeutics-Reports-Fiscal-Year-2024-Financial-and-Operational-Results.html
https://www.globenewswire.com/news-release/2024/04/26/2870789/0/en/Appili-Therapeutics-Announces-Additional-Bridge-Loan-from-Bloom-Burton-Co.html
https://www.globenewswire.com/news-release/2024/04/02/2855850/0/en/Appili-Therapeutics-Signs-Definitive-Agreement-to-be-Acquired-by-Aditxt-Inc.html
https://www.globenewswire.com//news-release/2024/03/12/2844411/0/en/Researchers-Publish-Manuscript-on-the-Prevention-and-Emergency-Response-to-Tularemia-Outbreaks.html
https://www.globenewswire.com//news-release/2024/02/13/2828710/0/en/Appili-Therapeutics-Reports-Financial-and-Operational-Results-for-Third-Quarter-of-Fiscal-Year-2024.html